Dr Richard Buchta Appointed as Director of Beroni Group
30 juin 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, June 30, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Group Issues US$2.97 million of Convertible Notes to Fund Growth Plans
27 mai 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, May 27, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Group R&D Team Identifies 24 Types of Nanobodies for Rapid Detection and Treatment of Coronavirus (COVID-19)
08 mai 2020 09h30 HE
|
Beroni Group Limited
- Granted Approval by China Ministry of Commerce to Export Detection Kits Globally -- Obtained CE Certification by European Union - NEW YORK and SYDNEY, Australia, May 08, 2020 (GLOBE NEWSWIRE)...
Beroni Group Included in List of Commercial Manufacturers and Laboratories Who Have Notified US FDA of Validated Serology Tests for COVID-19
03 avr. 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise...
Beroni Group’s SARS-CoV-2 IgG/IgM Antibody Detection Kit Received CE Certification
03 avr. 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, April 03, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise...
Beroni Group Announces Submission of Emergency Use Authorization to US FDA for its COVID-19 Rapid Test Detection Kit
26 mars 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, March 26, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise...
Beroni Group Advances Research and Development of Medical Solution for Coronavirus (COVID-19)
09 mars 2020 09h30 HE
|
Beroni Group Limited
- Cytological Experiments Commenced in March 2020 - - Clinical Trials to Commence in April 2020 - NEW YORK and SYDNEY, Australia, March 09, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF;...
Beroni Group Collaborates with Tianjin University to Develop Novel Solution for Coronavirus (COVID-19)
20 févr. 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Feb. 20, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Group Featured in New Research Initiation Report
12 févr. 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Feb. 12, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...
Beroni Group Announces Webcast from Biotech Showcase™ 2020 in San Francisco, USA
14 janv. 2020 09h30 HE
|
Beroni Group Limited
NEW YORK and SYDNEY, Australia, Jan. 14, 2020 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni” or the “Company”), an international diversified biopharmaceutical enterprise focused...